T-Care AI
Smart post-transition support for transgender health
A digital AI assistant for transgender individuals who have undergone hormonal and/or surgical gender affirmation, focusing on long-term health and body confidence.
The Problem
Transgender patients after completing hormonal or surgical transition face significant challenges in their ongoing healthcare journey.
Lack of Systematic Support
No structured post-transition care pathways exist, leaving patients to navigate their health independently.
High Anxiety Levels
Unstable wellbeing creates significant stress without proper monitoring systems in place.
Fragmented Tools
Patients rely on forums, notes, and sporadic doctor visits that fail to provide security and structure.
Service Gap
Existing services focus on pre-transition or during transition, not the critical post-transition phase.
Our Solution
T-Care AI is a digital healthtech platform for transgender individuals in the post-transition phase, offering comprehensive support through innovative technology.
Personalised Monitoring
Track well-being and hormonal changes with precision-tailored insights for your unique journey.
AI-Powered Analysis
Identify negative patterns and receive lifestyle recommendations based on your data.
Privacy First
GDPR-compliant with data stored on your device or in European cloud infrastructure.
Clinical Foundation
Built on deep expertise in endocrinology and gender affirmation surgery.
Technological Innovation
T-Care AI represents a unique combination of clinical endocrinology, digital monitoring, and ethical artificial intelligence application within EU and French healthcare priorities.
01
AI Personalisation Engine
Builds behavioural and hormonal profiles, detects deterioration patterns, provides adaptive recommendations for sleep, activity, nutrition, and emotional state.
02
NLP Data Collection Interface
User-friendly dialogue system that can query, clarify, and explain recommendations naturally.
03
Privacy by Design
All data stored locally or in encrypted European cloud. GDPR-compliant with ethical AI training protocols.
04
French Health System Integration
Potential integration with DMP (Dossier Médical Partagé) and interoperability with e-santé systems via HL7/FHIR standards.
05
Co-Design Methodology
Platform developed jointly with transgender community to adapt UX, language, metrics, and logic to real user needs.

T-Care AI is not just a tracker — it's an intelligent, secure, and ethically developed digital health tool of the new generation.
Target Audience
Age Range
18–45 years old
Transition Status
Completed or undergoing hormonal/surgical transition
Geography
Europe, USA, Canada
Digital Profile
Digital-native users sensitive to health and safety
Our primary users are transgender and non-binary individuals who have navigated the transition process and seek ongoing support for their long-term health and wellbeing.
Market Opportunity
$40.3B
Total Addressable Market (TAM)
Global market for gender transition services by 2032
$600M
Serviceable Available Market (SAM)
Digital health support for transgender individuals annually
€30-50M
Serviceable Obtainable Market (SOM)
Europe and USA post-transition digital-ready market per year: ~200K users willing to pay for digital support, with an average annual spend of €150
Competitive Landscape
Post-Transition Focus
AI Health Tracker
Clinical Expertise
GDPR Compliant
Community Co-Design
Business Model
Freemium
Basic tracker, visualisation, reminders at no cost
Subscription
€10–15/month for advanced features, personalised recommendations, data archive and export
B2B / B2G
White-label solutions for clinics, NGOs, insurance companies, government platforms
Why Now
Rapid Population Growth
The number of adult transgender individuals in the USA increased from 1.4 million in 2016 to 1.6 million in 2022 (+14% in 6 years, Williams Institute, UCLA).
European Surge
Transgender individuals seeking medical support in Europe increased 2–3 times over the past 5 years, depending on country (ILGA-Europe, 2023).
Unmet Need
Over 50% of transgender people who completed transition report insufficient medical and psycho-emotional support long-term (WPATH, 2022).
Market Expansion
Gender-affirming hormone therapy market in USA valued at $1.6 billion and growing (GrandViewResearch, 2023). Digital health in Europe grew 20%+ CAGR since 2020.
Our Founding Team
Dmitrii Derkach, MD
CEO
  • Endocrinologist and surgeon with 25+ years of experience
  • Specialist in gender affirmation surgery and endocrine gynecology
  • Author of 50+ publications and 2 patents
  • Expert in laparoscopic adrenalectomy and gender-affirming procedures
Maksim Mescheriakov
CMO
  • Performance marketing specialist with 4+ years experience
  • Expert in Meta Ads, Google Ads, LinkedIn Ads for international clients
  • Specialized in lead generation, CRM integration, and audience research
Mikhail Ilichev
CBDO
  • Serial entrepreneur & senior executive in digital media, streaming and AdTech with 15+ years of leadership experience
  • Proven track record building and scaling platforms across B2C, B2B, and creator/partner ecosystems
  • Co-founded an AI voice advertising startup with international traction; secured a $1.3M seed round and became an SXSW Accelerator finalist
Why We're Different
Clinical Excellence
Our founder is an endocrinologist and surgeon with 20+ years of experience and dozens of gender affirmation surgeries, including work with intersex patients.
The co-founder brings international startup experience in digital marketing and product management within wellness and technology sectors.
Community-Centred Design
We work in co-design format, involving the transgender community at every stage of product development.
Focused on the EU and French markets, we align with France 2030 priorities: digital health, artificial intelligence, and inclusion.
Join us in revolutionising post-transition healthcare support through innovative technology and compassionate design